Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: a Canadian payer perspective
Sorensen, S V, Kansal, A R, Connolly, S, Peng, S, Linnehan, J, Bradley-Kennedy, C, Plumb, J M
Published in Thrombosis and haemostasis (01.05.2011)
Published in Thrombosis and haemostasis (01.05.2011)
Get more information
Journal Article